home All News open_in_new Full Article

Cybin Receives European Approval for EMBRACE, a Multinational Phase 3 Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder

– EMBRACE, the second study within the Phase 3 PARADIGM program, will enroll 330 participants at approximately 60 clinical sites across the United States, Europe, the United Kingdom, and Australia – – European CTA approval to initiate the EMBRACE study in Ireland, Poland, and Greece has been received – – Recently received Medicines and Healthcare […]


today 6 d. ago attach_file Economics

attach_file Events
attach_file Other
attach_file Economics
attach_file Society
attach_file Other
attach_file Other
attach_file Economics
attach_file Other
attach_file Events
attach_file Science
attach_file Other
attach_file Economics
attach_file Sport
attach_file Economics
attach_file Other
attach_file Sport
attach_file Politics
attach_file Economics
attach_file Events
attach_file Politics


ID: 1251279739
Add Watch Country

arrow_drop_down